Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-075695
Filing Date
2025-04-08
Accepted
2025-04-08 16:05:26
Documents
23
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d664816ddef14a.htm   iXBRL DEF 14A 644757
6 GRAPHIC g664816g00a02.jpg GRAPHIC 22797
7 GRAPHIC g664816g00a03.jpg GRAPHIC 27686
8 GRAPHIC g664816g01n89.jpg GRAPHIC 30188
9 GRAPHIC g664816g66a01.jpg GRAPHIC 404221
10 GRAPHIC g664816g66a02.jpg GRAPHIC 208327
11 GRAPHIC g664816g66s27.jpg GRAPHIC 127776
12 GRAPHIC g664816g82i12.jpg GRAPHIC 113059
13 GRAPHIC g664816g82y25.jpg GRAPHIC 123422
14 GRAPHIC g664816g85t41.jpg GRAPHIC 124284
  Complete submission text file 0001193125-25-075695.txt   4101083

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20241231.xsd EX-101.SCH 3716
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20241231_def.xml EX-101.DEF 3410
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20241231_lab.xml EX-101.LAB 3230
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20241231_pre.xml EX-101.PRE 2283
25 EXTRACTED XBRL INSTANCE DOCUMENT d664816ddef14a_htm.xml XML 224458
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 25821948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)